Home
Charles McWherter, President of R&D: CymaBay Therapeutics CBAY Sell · Filed 24/01/22
Trade details
- Type
- Insider sale
- Amount
- $65,727.48
- Shares · price
- 2,778 sh · $23.66 a share
- Held after
- 15,000 sh
- Trade date
- 24/01/19
- Filed
- 24/01/22
- Days to filing
- 3 days
Sold 15.6% of holdings
- Share of holding sold
- 15.6%
CymaBay Therapeutics trades, last 26 weeks
What else happened in CymaBay Therapeutics around then
Filed or reported within 30 days of the trade day · 23/12/20~24/02/18Charles McWherter's recent trades
- Charles McWherter
Buy89bio
Buy89bio
ETNB
$67.1K
10,000 sh
$67.1K
Filed 25/01/23
Traded 25/01/22
- Charles McWherter
Buy89bio
Buy89bio
ETNB
$32.8K
5,000 sh
$32.8K
Filed 25/01/23
Traded 25/01/21
- Charles McWherter
Buy89bio
Buy89bio
ETNB
$80K
10,000 sh
$80K
Filed 24/12/09
Traded 24/12/05
- Charles McWherter
Sell10b5-1 planCymaBay Therapeutics
Sell10b5-1 planCymaBay Therapeutics
CBAY
$197.3K
8,334 sh
$197.3K
Filed 24/01/22
Traded 24/01/19
- Charles McWherter
Sell10b5-1 planCymaBay Therapeutics
Sell10b5-1 planCymaBay Therapeutics
CBAY
$74K
3,125 sh
$74K
Filed 24/01/22
Traded 24/01/19